Cargando…

Treatment with the Antipsychotic Agent, Risperidone, Reduces Disease Severity in Experimental Autoimmune Encephalomyelitis

Recent studies have demonstrated that atypical antipsychotic agents, which are known to antagonize dopamine D2 and serotonin 5-HT(2a) receptors, have immunomodulatory properties. Given the potential of these drugs to modulate the immune system both peripherally and within the central nervous system,...

Descripción completa

Detalles Bibliográficos
Autores principales:	O'Sullivan, David, Green, Laura, Stone, Sarrabeth, Zareie, Pirooz, Kharkrang, Marie, Fong, Dahna, Connor, Bronwen, La Flamme, Anne Camille
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4130540/ https://www.ncbi.nlm.nih.gov/pubmed/25116424 http://dx.doi.org/10.1371/journal.pone.0104430

Ejemplares similares

Enhanced disease reduction using clozapine, an atypical antipsychotic agent, and glatiramer acetate combination therapy in experimental autoimmune encephalomyelitis
por: Green, Laura K, et al.
Publicado: (2017)

Amelioration of experimental autoimmune encephalomyelitis by clozapine is not associated with defective CD4 T cell responses
por: Zareie, Pirooz, et al.
Publicado: (2017)

Clozapine reduces infiltration into the CNS by targeting migration in experimental autoimmune encephalomyelitis
por: Robichon, Katharina, et al.
Publicado: (2020)

Type II-Activated Murine Macrophages Produce IL-4
por: La Flamme, Anne Camille, et al.
Publicado: (2012)

Role of nuclear factor κB in multiple sclerosis and experimental autoimmune encephalomyelitis
por: Yue, Yuan, et al.
Publicado: (2018)

Localisation of clozapine during experimental autoimmune encephalomyelitis and its impact on dopamine and its receptors
por: Robichon, Katharina, et al.
Publicado: (2021)

Targeting Innate Receptors with MIS416 Reshapes Th Responses and Suppresses CNS Disease in a Mouse Model of Multiple Sclerosis
por: White, Madeleine, et al.
Publicado: (2014)

Type II Activation of Macrophages and Microglia by Immune Complexes Enhances Th17 Biasing in an IL-6-Independent Manner
por: Stone, Sarrabeth, et al.
Publicado: (2016)

Inhibition of Vascular Endothelial Growth Factor Receptor 2 Exacerbates Loss of Lower Motor Neurons and Axons during Experimental Autoimmune Encephalomyelitis
por: Stanojlovic, Milos, et al.
Publicado: (2016)

Innate IFN-γ ameliorates experimental autoimmune encephalomyelitis and promotes myeloid expansion and PDL-1 expression
por: White, Madeleine P. J., et al.
Publicado: (2018)

Sexual dysfunction in patients with schizophrenia treated with conventional antipsychotics or risperidone
por: Liu-Seifert, Hong, et al.
Publicado: (2009)

The antipsychotic medication, risperidone, causes global immunosuppression in healthy mice
por: May, Meghan, et al.
Publicado: (2019)

Movement Disorders in Elderly Users of Risperidone and First Generation Antipsychotic Agents: A Canadian Population-Based Study
por: Vasilyeva, Irina, et al.
Publicado: (2013)

Safety and acceptability of clozapine and risperidone in progressive multiple sclerosis: a phase I, randomised, blinded, placebo-controlled trial
por: La Flamme, Anne C, et al.
Publicado: (2020)

Paliperidone palmitate and risperidone long-acting injectable in subjects with schizophrenia recently treated with oral risperidone or other oral antipsychotics
por: Alphs, Larry, et al.
Publicado: (2013)

Neuronal microRNA regulation in Experimental Autoimmune Encephalomyelitis
por: Juźwik, Camille A., et al.
Publicado: (2018)

Designed proteinoid polymers and nanoparticles encapsulating risperidone for enhanced antipsychotic activity
por: Lugasi, L., et al.
Publicado: (2020)

Proteinoid Nanocapsules as Drug Delivery System for Improving Antipsychotic Activity of Risperidone
por: Lugasi, Liroy, et al.
Publicado: (2020)

Amelioration of Experimental Autoimmune Encephalomyelitis by Anatabine
por: Paris, Daniel, et al.
Publicado: (2013)

Environmental Influences in Experimental Autoimmune Encephalomyelitis
por: Constantinescu, Cris S
Publicado: (2005)

STRUCTURE OF THE D(2) DOPAMINE RECEPTOR BOUND TO THE ATYPICAL ANTIPSYCHOTIC DRUG RISPERIDONE
por: Wang, Sheng, et al.
Publicado: (2018)

Does risperidone seem safe in patients with antipsychotic-induced leukoneutropenia? Case report
por: Abid, W., et al.
Publicado: (2023)

Erythropoietin and autoimmune neuroinflammation: lessons from experimental autoimmune encephalomyelitis and experimental autoimmune neuritis
por: Shin, Taekyun, et al.
Publicado: (2012)

Loss of T-bet, But Not STAT1, Prevents the Development of Experimental Autoimmune Encephalomyelitis
por: Bettelli, Estelle, et al.
Publicado: (2004)

Angiogenesis in multiple sclerosis and experimental autoimmune encephalomyelitis
por: Girolamo, Francesco, et al.
Publicado: (2014)

Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis
por: Basler, Michael, et al.
Publicado: (2014)

Contribution of Pannexin1 to Experimental Autoimmune Encephalomyelitis
por: Lutz, Sarah E., et al.
Publicado: (2013)

The Role of ERK Signaling in Experimental Autoimmune Encephalomyelitis
por: Birkner, Katharina, et al.
Publicado: (2017)

Amelioration of experimental autoimmune encephalomyelitis by Ishige okamurae
por: Ahn, Meejung, et al.
Publicado: (2018)

Oryeongsan (Goreisan) Ameliorates Experimental Autoimmune Encephalomyelitis
por: Inada, Rino, et al.
Publicado: (2019)

Opposing T Cell Responses in Experimental Autoimmune Encephalomyelitis
por: Saligrama, Naresha, et al.
Publicado: (2019)

Molecular effects of curcumin on the experimental autoimmune encephalomyelitis
por: Mavaddatiyan, Laleh, et al.
Publicado: (2021)

Patient perspectives on use of long-acting antipsychotics in bipolar disorder: focus on risperidone injection
por: Samalin, L, et al.
Publicado: (2010)

Behavioral Mechanisms That Depend on Dopamine and Serotonin in Caenorhabditis elegans Interact With the Antipsychotics Risperidone and Aripiprazole
por: Osuna-Luque, Jaime, et al.
Publicado: (2018)

Risperidone-Induced Tardive Akathisia: A Rare Antipsychotic Side Effect with Management Issues
por: Mishra, Biswa Ranjan, et al.
Publicado: (2019)

The atypical antipsychotic risperidone targets hypothalamic melanocortin 4 receptors to cause weight gain
por: Li, Li, et al.
Publicado: (2021)

Endothelial cell‐derived oxysterol ablation attenuates experimental autoimmune encephalomyelitis
por: Ruiz, Florian, et al.
Publicado: (2023)

Distinctive waves of innate immune response in the retina in experimental autoimmune encephalomyelitis
por: Cruz-Herranz, Andrés, et al.
Publicado: (2021)

The circumventricular organs participate in the immunopathogenesis of experimental autoimmune encephalomyelitis
por: Schulz, Martina, et al.
Publicado: (2005)

Mgat5 Deficiency in T Cells and Experimental Autoimmune Encephalomyelitis
por: Grigorian, Ani, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_0ejupg17l9mbklgvo9jhctva04